Greenwich LifeSciences, Inc.

NASDAQ:GLSI

13.11 (USD) • At close January 6, 2025
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q4
Omzet 0000.00500000000000000000000
Kosten van de omzet 00.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.001000000000.001
Brutowinst 0-0.001-0.0010.005-0.001-0.001-0.001-0.001-0.001-0.001-0.001-0.001-0.001-0.001-0.00100000000-0.001
Brutowinstmarge 0000.83300000000000000000000
Onderzoek- en ontwikkelingskosten 2.2922.3082.1952.3332.1581.381.8282.4581.7230.6331.6612.0640.6570.5570.2820.5990.1580.1510.150.2590.2851.9370.1261.161
Algemene en administratieve kosten 0.4370.3540.3430.5030.3450.3680.4130.4370.660.140.3280.3130.210.1970.3190.5530.0990.060.0950.0780.0520.6670.0220
Verkoop- en marketingkosten 00-0.001-0.00100000000000000000000
Verkoop-, algemene en administratieve kosten 0.4370.3540.3420.5020.3450.3680.4130.4370.660.140.3280.3130.210.1970.3190.5530.0990.060.0950.0780.0520.6670.0220.394
Overige kosten 002.195000000000000000000000
Bedrijfskosten 2.7292.6612.5362.8352.5031.7482.2412.8952.3830.7731.9892.3770.8670.7530.6011.1520.2570.210.2450.3370.3362.6040.1491.555
Bedrijfsresultaat -2.729-2.661-2.537-2.836-2.503-1.748-2.241-2.895-2.383-0.773-1.989-2.377-0.867-0.753-0.601-1.152-0.257-0.21-0.245-0.337-0.336-2.604-0.149-1.556
Bedrijfsresultaat ratio 000-523.44600000000000000000000
Totaal overige inkomsten en kosten netto 0.060.0550.0640.0890.1110.1190.1160.1040.0640.0270.020.0170.0040.0040.0040.00100000000
Inkomen voor belasting -2.669-2.607-2.473-2.747-2.392-1.628-2.125-2.791-2.319-0.746-1.97-2.361-0.863-0.75-0.597-1.151-0.257-0.21-0.245-0.337-0.336-2.604-0.149-1.556
Inkomen voor belasting ratio 000-506.96500000000000000000000
Belastingkosten 00-2.538-00.04-0.121-0.116-0.151-0.064-0.027-0.020000-0.71200000-0.00100
Nettowinst -2.669-2.607-2.473-2.747-2.392-1.628-2.009-2.64-2.255-0.719-1.95-2.361-0.863-0.75-0.597-1.151-0.257-0.21-0.245-0.337-0.336-2.604-0.149-1.556
Nettowinstmarge 000-506.96500000000000000000000
WPA (Winst Per Aandeel) -0.2-0.2-0.19-0.21-0.19-0.13-0.16-0.21-0.18-0.056-0.15-0.18-0.067-0.058-0.047-0.13-0.022-0.018-0.02-0.028-0.028-0.22-0.74-0.13
Verwaterde WPA -0.2-0.2-0.19-0.21-0.19-0.13-0.16-0.21-0.18-0.056-0.15-0.18-0.067-0.058-0.047-0.13-0.022-0.018-0.02-0.028-0.028-0.22-0.73-0.13
EBITDA -2.728-2.661-2.536-2.835-2.502-1.747-2.24-2.894-2.382-0.772-1.988-2.376-0.866-0.753-0.6-1.151-0.256-0.21-0.244-0.336-0.335-2.603-0.148-1.555
EBITDA ratio 000-523.2800000000000000000000